Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniosynostoses | 9 | 2023 | 53 | 3.580 |
Why?
|
| Reconstructive Surgical Procedures | 8 | 2021 | 191 | 2.250 |
Why?
|
| Orbital Fractures | 3 | 2022 | 6 | 2.010 |
Why?
|
| Osteogenesis, Distraction | 5 | 2022 | 17 | 1.810 |
Why?
|
| Cleft Palate | 9 | 2022 | 24 | 1.640 |
Why?
|
| Bone Transplantation | 6 | 2021 | 49 | 1.510 |
Why?
|
| Pierre Robin Syndrome | 5 | 2022 | 7 | 1.450 |
Why?
|
| Bone Regeneration | 5 | 2023 | 33 | 1.330 |
Why?
|
| Mandible | 6 | 2022 | 39 | 1.270 |
Why?
|
| Craniofacial Dysostosis | 2 | 2022 | 6 | 1.230 |
Why?
|
| Cranial Sutures | 4 | 2022 | 13 | 1.020 |
Why?
|
| Airway Obstruction | 4 | 2022 | 29 | 1.020 |
Why?
|
| Infant | 14 | 2023 | 1024 | 1.000 |
Why?
|
| Tissue Engineering | 7 | 2023 | 695 | 0.960 |
Why?
|
| Periosteum | 4 | 2015 | 8 | 0.960 |
Why?
|
| Skull | 4 | 2020 | 45 | 0.880 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2015 | 21 | 0.880 |
Why?
|
| Cleft Lip | 6 | 2022 | 15 | 0.870 |
Why?
|
| Humans | 46 | 2023 | 32284 | 0.820 |
Why?
|
| Esthetics, Dental | 1 | 2022 | 1 | 0.740 |
Why?
|
| Retrospective Studies | 15 | 2023 | 3612 | 0.710 |
Why?
|
| Models, Anatomic | 1 | 2022 | 37 | 0.700 |
Why?
|
| Germ Cells | 4 | 2011 | 11 | 0.680 |
Why?
|
| Enophthalmos | 1 | 2021 | 2 | 0.660 |
Why?
|
| Zygomatic Fractures | 1 | 2021 | 3 | 0.660 |
Why?
|
| Orbital Implants | 1 | 2021 | 3 | 0.660 |
Why?
|
| Maxillary Fractures | 1 | 2021 | 4 | 0.660 |
Why?
|
| Orbit | 2 | 2020 | 19 | 0.660 |
Why?
|
| Face | 2 | 2018 | 29 | 0.640 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2020 | 7 | 0.630 |
Why?
|
| Maxilla | 3 | 2020 | 10 | 0.610 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2015 | 73 | 0.610 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 56 | 0.600 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 38 | 0.580 |
Why?
|
| Amniotic Band Syndrome | 1 | 2018 | 1 | 0.570 |
Why?
|
| Hypertelorism | 1 | 2018 | 1 | 0.570 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2018 | 4 | 0.570 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 65 | 0.570 |
Why?
|
| Hand Deformities, Congenital | 1 | 2018 | 8 | 0.570 |
Why?
|
| Ganglion Cysts | 1 | 2018 | 8 | 0.560 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 27 | 0.560 |
Why?
|
| Fracture Fixation, Internal | 2 | 2019 | 128 | 0.550 |
Why?
|
| Tracheostomy | 2 | 2018 | 28 | 0.550 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 60 | 0.550 |
Why?
|
| Fibula | 2 | 2021 | 14 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2021 | 906 | 0.510 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 198 | 0.500 |
Why?
|
| Fracture Healing | 1 | 2017 | 44 | 0.500 |
Why?
|
| Tissue Scaffolds | 4 | 2023 | 431 | 0.500 |
Why?
|
| Tibia | 2 | 2021 | 54 | 0.490 |
Why?
|
| Infant, Newborn | 6 | 2022 | 674 | 0.480 |
Why?
|
| Treatment Outcome | 10 | 2023 | 3410 | 0.480 |
Why?
|
| Tibial Fractures | 1 | 2015 | 31 | 0.450 |
Why?
|
| Surgery, Plastic | 3 | 2022 | 29 | 0.430 |
Why?
|
| Female | 23 | 2022 | 19954 | 0.430 |
Why?
|
| Stem Cell Factor | 3 | 2011 | 11 | 0.410 |
Why?
|
| Cell Movement | 4 | 2011 | 165 | 0.400 |
Why?
|
| Craniotomy | 3 | 2023 | 38 | 0.370 |
Why?
|
| Occipital Bone | 2 | 2022 | 14 | 0.360 |
Why?
|
| Ultrasonics | 4 | 2006 | 22 | 0.360 |
Why?
|
| Sutures | 2 | 2022 | 19 | 0.360 |
Why?
|
| Male | 21 | 2021 | 19434 | 0.340 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2008 | 12 | 0.330 |
Why?
|
| Animals | 11 | 2017 | 8165 | 0.320 |
Why?
|
| Child | 9 | 2023 | 2446 | 0.310 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 263 | 0.300 |
Why?
|
| Orthopedic Procedures | 2 | 2020 | 89 | 0.290 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2006 | 40 | 0.290 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 162 | 0.280 |
Why?
|
| Swine | 3 | 2015 | 229 | 0.280 |
Why?
|
| Osteogenesis | 3 | 2023 | 79 | 0.280 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 219 | 0.270 |
Why?
|
| Apoptosis | 2 | 2008 | 367 | 0.270 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2008 | 11 | 0.270 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 31 | 0.270 |
Why?
|
| Nasal Septum | 2 | 2018 | 4 | 0.260 |
Why?
|
| Ilium | 2 | 2016 | 15 | 0.250 |
Why?
|
| Cell Membrane Permeability | 1 | 2006 | 19 | 0.250 |
Why?
|
| Fellowships and Scholarships | 2 | 2017 | 51 | 0.240 |
Why?
|
| Postoperative Complications | 3 | 2020 | 818 | 0.230 |
Why?
|
| Surgical Flaps | 2 | 2020 | 75 | 0.220 |
Why?
|
| Facial Bones | 2 | 2018 | 8 | 0.220 |
Why?
|
| Cell Proliferation | 1 | 2006 | 599 | 0.210 |
Why?
|
| Surgical Equipment | 2 | 2020 | 8 | 0.200 |
Why?
|
| Ink | 1 | 2023 | 11 | 0.200 |
Why?
|
| Transplantation, Homologous | 2 | 2015 | 156 | 0.190 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2022 | 1 | 0.190 |
Why?
|
| Iris Diseases | 1 | 2022 | 1 | 0.190 |
Why?
|
| Hypopigmentation | 1 | 2022 | 7 | 0.190 |
Why?
|
| Nerve Transfer | 1 | 2022 | 19 | 0.180 |
Why?
|
| Foramen Magnum | 1 | 2022 | 1 | 0.180 |
Why?
|
| Computers | 1 | 2022 | 22 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2022 | 93 | 0.170 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2018 | 21 | 0.160 |
Why?
|
| Internship and Residency | 2 | 2022 | 317 | 0.160 |
Why?
|
| Neuroendoscopy | 1 | 2020 | 3 | 0.160 |
Why?
|
| Pharynx | 1 | 2020 | 13 | 0.160 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 8 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2020 | 47 | 0.160 |
Why?
|
| Osteotomy | 2 | 2023 | 54 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 104 | 0.150 |
Why?
|
| Adipose Tissue | 2 | 2014 | 318 | 0.150 |
Why?
|
| Jaw Fixation Techniques | 1 | 2019 | 2 | 0.150 |
Why?
|
| Mandibular Fractures | 1 | 2019 | 7 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2014 | 452 | 0.140 |
Why?
|
| Craniofacial Abnormalities | 3 | 2017 | 14 | 0.140 |
Why?
|
| Dizziness | 1 | 2018 | 7 | 0.140 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2018 | 30 | 0.140 |
Why?
|
| Headache | 1 | 2018 | 72 | 0.140 |
Why?
|
| Neuralgia | 1 | 2018 | 45 | 0.140 |
Why?
|
| Palatal Obturators | 1 | 2018 | 1 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 56 | 0.140 |
Why?
|
| Dipyridamole | 1 | 2017 | 3 | 0.130 |
Why?
|
| Ceramics | 1 | 2017 | 7 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 17 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 70 | 0.130 |
Why?
|
| Time Factors | 2 | 2020 | 2196 | 0.120 |
Why?
|
| Maxillary Neoplasms | 1 | 2016 | 2 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 251 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 502 | 0.120 |
Why?
|
| Professional Practice Location | 1 | 2016 | 1 | 0.120 |
Why?
|
| Goldenhar Syndrome | 1 | 2016 | 3 | 0.120 |
Why?
|
| Alveolar Ridge Augmentation | 1 | 2016 | 2 | 0.120 |
Why?
|
| Nasal Obstruction | 1 | 2016 | 5 | 0.120 |
Why?
|
| Surgical Instruments | 1 | 2016 | 25 | 0.120 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2016 | 26 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 550 | 0.120 |
Why?
|
| Cartilage | 1 | 2016 | 33 | 0.120 |
Why?
|
| Outpatients | 1 | 2016 | 57 | 0.120 |
Why?
|
| Career Choice | 1 | 2016 | 43 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 16 | 0.120 |
Why?
|
| Publishing | 1 | 2017 | 66 | 0.120 |
Why?
|
| Ribs | 1 | 2016 | 43 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 161 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2018 | 858 | 0.110 |
Why?
|
| Mice | 4 | 2011 | 2544 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2017 | 178 | 0.110 |
Why?
|
| Parents | 1 | 2016 | 151 | 0.110 |
Why?
|
| Biofilms | 2 | 2004 | 23 | 0.100 |
Why?
|
| Wound Healing | 1 | 2015 | 180 | 0.100 |
Why?
|
| Pliability | 1 | 2014 | 4 | 0.100 |
Why?
|
| Tissue Preservation | 1 | 2014 | 8 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 106 | 0.100 |
Why?
|
| Chondrogenesis | 1 | 2014 | 19 | 0.100 |
Why?
|
| Absorbable Implants | 1 | 2014 | 24 | 0.100 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 45 | 0.100 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2014 | 35 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2016 | 1840 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 95 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 1424 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2016 | 329 | 0.100 |
Why?
|
| Adult | 5 | 2019 | 9263 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2011 | 68 | 0.100 |
Why?
|
| Facial Transplantation | 1 | 2013 | 8 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 189 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 1211 | 0.100 |
Why?
|
| Length of Stay | 1 | 2014 | 321 | 0.100 |
Why?
|
| Allantois | 2 | 2011 | 3 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 167 | 0.090 |
Why?
|
| Scalp | 1 | 2013 | 35 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2023 | 91 | 0.090 |
Why?
|
| Collagen | 1 | 2014 | 229 | 0.090 |
Why?
|
| Ultrasonic Therapy | 2 | 2009 | 4 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2011 | 109 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2021 | 1248 | 0.080 |
Why?
|
| Middle Aged | 3 | 2019 | 11843 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2009 | 441 | 0.080 |
Why?
|
| Osteotomy, Le Fort | 1 | 2009 | 3 | 0.080 |
Why?
|
| Quadriceps Muscle | 1 | 2010 | 29 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2009 | 24 | 0.070 |
Why?
|
| Sacrococcygeal Region | 1 | 2008 | 6 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2008 | 20 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 10 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 49 | 0.070 |
Why?
|
| DNA Primers | 1 | 2008 | 85 | 0.070 |
Why?
|
| Cell Survival | 2 | 2009 | 286 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 74 | 0.070 |
Why?
|
| Gestational Age | 1 | 2008 | 125 | 0.060 |
Why?
|
| Base Sequence | 1 | 2008 | 256 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 122 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 149 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 254 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1485 | 0.060 |
Why?
|
| Gonads | 1 | 2006 | 3 | 0.060 |
Why?
|
| Mesentery | 1 | 2006 | 6 | 0.060 |
Why?
|
| Genitalia | 1 | 2006 | 9 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 24 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2006 | 9 | 0.060 |
Why?
|
| Cephalosporins | 1 | 2006 | 8 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2006 | 41 | 0.060 |
Why?
|
| Cadaver | 3 | 2013 | 151 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 2652 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2018 | 455 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2004 | 336 | 0.050 |
Why?
|
| Gentamicins | 1 | 2004 | 4 | 0.050 |
Why?
|
| Staphylococcus epidermidis | 1 | 2004 | 5 | 0.050 |
Why?
|
| Vancomycin | 1 | 2004 | 17 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2004 | 103 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2238 | 0.050 |
Why?
|
| Micelles | 1 | 2002 | 7 | 0.050 |
Why?
|
| Iris | 1 | 2022 | 7 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2002 | 9 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 29 | 0.040 |
Why?
|
| Head | 1 | 2022 | 57 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 105 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2013 | 309 | 0.040 |
Why?
|
| Executive Function | 1 | 2020 | 52 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 238 | 0.040 |
Why?
|
| Nose | 1 | 2020 | 12 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 3521 | 0.040 |
Why?
|
| Bone Screws | 1 | 2019 | 56 | 0.040 |
Why?
|
| Bone Plates | 1 | 2019 | 72 | 0.040 |
Why?
|
| Fiber Optic Technology | 1 | 2018 | 13 | 0.040 |
Why?
|
| Laryngeal Masks | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 191 | 0.030 |
Why?
|
| Device Removal | 1 | 2018 | 39 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2017 | 9 | 0.030 |
Why?
|
| Polysomnography | 1 | 2017 | 39 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 650 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 95 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 194 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 247 | 0.030 |
Why?
|
| Publications | 1 | 2017 | 9 | 0.030 |
Why?
|
| North America | 1 | 2016 | 31 | 0.030 |
Why?
|
| North Carolina | 1 | 2020 | 1299 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 48 | 0.030 |
Why?
|
| Canada | 1 | 2016 | 64 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 48 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 76 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 743 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 287 | 0.030 |
Why?
|
| Software | 1 | 2016 | 125 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 45 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 130 | 0.030 |
Why?
|
| Carotid Artery, External | 1 | 2013 | 2 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 2013 | 7 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2013 | 24 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 39 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 50 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 243 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 16 | 0.020 |
Why?
|
| Soft Tissue Injuries | 1 | 2010 | 18 | 0.020 |
Why?
|
| Zygoma | 1 | 2009 | 3 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 499 | 0.020 |
Why?
|
| Eyelids | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cheek | 1 | 2009 | 6 | 0.020 |
Why?
|
| Endoscopy | 1 | 2009 | 54 | 0.020 |
Why?
|
| Digestive System | 1 | 2009 | 5 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 497 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 36 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 74 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 555 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4079 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2009 | 716 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 73 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 82 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 31 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 214 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 78 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 8 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2002 | 14 | 0.010 |
Why?
|
| Hela Cells | 1 | 2002 | 75 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 165 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 52 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 709 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 184 | 0.010 |
Why?
|